Nabi Biopharmaceuticals Initiates S. Epidermidis Vaccine Phase I Study
CDC Recommends Meningococcal Vaccine for Adolescents and College Freshmen
Benching Bacteria from Athletics: New Sporting Goods Line Answers Call for Protection Against Antibiotic-Resistant Staph Infections
FDA Approves MERREM IV for Complicated Skin and Skin Structure Infections
Infectious Disease Doctors Issue Warning on Flu Pandemic
Study Demonstrates Clinical Efficacy of Telithromycin for Treatment of Mild to Moderate CAP
Middle Ear Infections are Caused by Biofilm Formation
Immediate Treatment After Suspected HIV Transmission May Do More Harm than Good
Can Your Pet Get You Sick? Expert Warns Against Zoonosis
Study Shows Nearly 80 Percent of Nurses Experience Needlestick Injuries Caring for Patients With Diabetes
What Types of Physicians Are Best to Treat Patients with HIV?
Michigan Department of Health Urges Citizens to Check Vaccination Status; Rubella Spreads in Small Southern Ontario Community
Human Cells Can "Silence" HIV Genes
MedAssets Contracts With Zassi Medical Evolutions, Inc. for Its Bowel Management System Designed to Improve Skin and Wound Care and Reduce Hospital-Acquired Infections
New Detection of an STD Not So New to the U.S. Prompts Fresh Concerns
SterilTek, Inc. and Breakthrough Management Group, Inc. Collaborate to Offer Healthcare Consulting Solutions
APIC Invited to Join National Campaign to Save 100,000 Lives Through Healthcare Improvement
Premier Announces Nation's Top Healthcare Providers; Hospitals Awarded for Work in Preventing Community-Acquired Pneumonia
STERIS Corporation Appoints John P. Wareham as Chairman of the Board of Directors
UCLA Study Assesses Cost-Effectiveness of Hepatitis B Drugs
MedMined Receives 2005 Outstanding Incubator Graduate Award from NBIA
International Team Determines Geographic Origin of Leprosy
NIH Sabin Gold Medal Awarded to Vaccine Developer Dr. Albert Z. Kapikian
Clinicians Still Have to Swab Those Tonsils
Lyme Disease Cases in Minnesota Hit Record High in 2004, Spread to New Areas
New Research Estimates MRSA Infections Cost U.S. Hospitals $3.2 Billion to $4.2 Billion Annually
HHS Announces $1.3 Billion in Funding to States for Bioterrorism Preparedness
Smith & Nephew Receives FDA Clearance for ACTICOAT Moisture Control
National Quality Forum Endorses Survey of Patient Perception of Care
Initial Anti-Biofilm Lab Results Suggest Ash Access Technology, Inc.'s Emerging Heparin-Replacement Catheter Lock Has Even Greater Infection-Prevention Attributes
